Director Jack Cogen Files Intent to Sell Over $104 Million in CoreWeave Stock
CRWV sits 66% above its 52-week low of $63.8.
Summary
CoreWeave Director Jack Cogen has filed a Form 144, indicating his intent to sell 986,540 shares of common stock, valued at approximately $104.46 million.
Key Events · Ownership and Investor Activity · CRWV
-
Director Files Intent to Sell
Jack Cogen, a Director of CoreWeave, has filed a Form 144 to sell 986,540 shares of common stock.
-
Significant Proposed Sale Value
The proposed sale is valued at approximately $104,464,720.60, representing 0.18% of the company's market capitalization and 0.22% of outstanding shares.
-
Founder Shares Being Monetized
The shares intended for sale were acquired as 'Founder Shares' on September 21, 2017.
-
Follows Recent Insider Distribution
This filing follows a period of significant insider selling, including large sales of derivative securities by 10% owner Magnetar Financial LLC in early May.
Analysis · CRWV · Technology
This Form 144 filing indicates Director Jack Cogen's intent to sell a substantial amount of CoreWeave common stock. The proposed sale of over $104 million adds to a recent pattern of insider distribution, following significant sales of derivative securities by a 10% owner in early May. While the company has reported strong financial results and secured major contracts, this director's intent to sell a notable portion of his holdings could be interpreted as a move to monetize long-held founder shares.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 29.6% of the 2856 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRWV was trading at $106.20 on NASDAQ in the Technology sector, with a market capitalization of approximately $57.8B. The 52-week trading range was $63.80 to $187.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.